TP53 and central nervous system cancer: Motivated by our previous research on the development of CPPs-based nanocomplexes to target and co-deliver payloads into glioma cells [45], in this work, we formulated BSA-coated peptide nanocomplexes for TMZ/p53 gene co-delivery.